Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.

[1]  D. Keech,et al.  Pyruvate carboxylase. , 2018, Current topics in cellular regulation.

[2]  B. Finck,et al.  Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism , 2018, Cellular and molecular gastroenterology and hepatology.

[3]  P. A. Crawford,et al.  Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome. , 2018, JCI insight.

[4]  D. Wasserman,et al.  Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates , 2018, The Journal of Biological Chemistry.

[5]  Robert A. Egnatchik,et al.  The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism , 2017, The Journal of Biological Chemistry.

[6]  H. Blasco,et al.  Liver involvement in urea cycle disorders: a review of the literature , 2017, Journal of Inherited Metabolic Disease.

[7]  P. Puchalska,et al.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. , 2017, Cell metabolism.

[8]  K. Petersen,et al.  Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism* , 2016, The Journal of Biological Chemistry.

[9]  W. Kaelin,et al.  Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes* , 2015, The Journal of Biological Chemistry.

[10]  J. Shelton,et al.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. , 2015, The Journal of clinical investigation.

[11]  Y. Kan,et al.  Nrf2 in health and disease: current and future clinical implications. , 2015, Clinical science.

[12]  D. Kelley,et al.  Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions. , 2015, American journal of physiology. Endocrinology and metabolism.

[13]  J. Rutter,et al.  Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis. , 2015, Cell metabolism.

[14]  J. Colca,et al.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling. , 2015, Cell metabolism.

[15]  Jamey D. Young,et al.  Mass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo. , 2015, American journal of physiology. Endocrinology and metabolism.

[16]  N. Boddaert,et al.  Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis , 2014, Molecular genetics and metabolism reports.

[17]  Jamey D. Young,et al.  INCA: a computational platform for isotopically non-stationary metabolic flux analysis , 2014, Bioinform..

[18]  K. Borges,et al.  Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy , 2014, Journal of neurochemistry.

[19]  J. Walter,et al.  Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin , 2014, European Journal of Pediatrics.

[20]  J. Jamie,et al.  Lysine metabolism in mammalian brain: an update on the importance of recent discoveries , 2013, Amino Acids.

[21]  K. Petersen,et al.  Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance , 2013, Diabetes.

[22]  P. Neufer,et al.  Linking mitochondrial bioenergetics to insulin resistance via redox biology , 2012, Trends in Endocrinology & Metabolism.

[23]  Raj Vuppalanchi,et al.  Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. , 2011, Journal of hepatology.

[24]  M. Brand,et al.  High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria , 2011, PloS one.

[25]  J. Harrow,et al.  A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.

[26]  C. Roe,et al.  Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis. , 2010, Molecular genetics and metabolism.

[27]  Guo-Fang Zhang,et al.  Interrelations between C4 Ketogenesis, C5 Ketogenesis, and Anaplerosis in the Perfused Rat Liver* , 2009, The Journal of Biological Chemistry.

[28]  D. Wasserman,et al.  Hepatic energy state is regulated by glucagon receptor signaling in mice. , 2009, The Journal of clinical investigation.

[29]  S. Kalhan,et al.  Glyceroneogenesis Is the Dominant Pathway for Triglyceride Glycerol Synthesis in Vivo in the Rat* , 2008, Journal of Biological Chemistry.

[30]  I. Rayment,et al.  Structure, mechanism and regulation of pyruvate carboxylase. , 2008, The Biochemical journal.

[31]  I. Rayment,et al.  Domain Architecture of Pyruvate Carboxylase, a Biotin-Dependent Multifunctional Enzyme , 2007, Science.

[32]  M. Magnuson,et al.  Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. , 2007, Cell metabolism.

[33]  À. García‐Cazorla,et al.  Pyruvate carboxylase deficiency: Metabolic characteristics and new neurological aspects , 2006, Annals of neurology.

[34]  F. Mochel,et al.  Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. , 2005, Molecular genetics and metabolism.

[35]  Craig R Malloy,et al.  Impaired Tricarboxylic Acid Cycle Activity in Mouse Livers Lacking Cytosolic Phosphoenolpyruvate Carboxykinase* , 2004, Journal of Biological Chemistry.

[36]  S. Burgess,et al.  Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative. , 2004, Analytical biochemistry.

[37]  R. Naviaux,et al.  Pyruvate carboxylase deficiency--insights from liver transplantation. , 2002, Molecular genetics and metabolism.

[38]  D. Rabier,et al.  Plasma Lysine Concentration and Availability of 2-Ketoglutarate in Liver Mitochondria , 2002, Journal of Inherited Metabolic Disease.

[39]  A. Sherry,et al.  An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans. , 2001, American journal of physiology. Endocrinology and metabolism.

[40]  R. Chalkley,et al.  Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism , 2000, Molecular and Cellular Biology.

[41]  B. Shushan,et al.  Development of a Method for Rapid Quantitation of Amino Acids by Liquid Chromatography-Tandem Mass Spectrometry (LC-MSMS) in Plasma , 2000, Clinical chemistry and laboratory medicine.

[42]  N. Heaton,et al.  Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. , 2000, Diabetes.

[43]  Ayesha Ahmad,et al.  Treatment of pyruvate carboxylase deficiency with high doses of citrate and aspartate. , 1999, American journal of medical genetics.

[44]  A. Ferraris,et al.  Mechanisms of Protection of Catalase by NADPH , 1999, The Journal of Biological Chemistry.

[45]  K. Lindor,et al.  The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease , 1999, American Journal of Gastroenterology.

[46]  R. Salto,et al.  Effects of starvation, diabetes and carbon tetrachloride intoxication on rat kidney cortex and liver pyruvate carboxylase levels. , 1996, Archives of physiology and biochemistry.

[47]  R. Bergman,et al.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. , 1996, The Journal of clinical investigation.

[48]  J. Wahren,et al.  Contributions of gluconeogenesis to glucose production in the fasted state. , 1996, The Journal of clinical investigation.

[49]  J. Wahren,et al.  Estimates of Krebs cycle activity and contributions of gluconeogenesis to hepatic glucose production in fasting healthy subjects and IDDM patients , 1995, Diabetologia.

[50]  H. Brunengraber,et al.  Reversibility of the mitochondrial isocitrate dehydrogenase reaction in the perfused rat liver. Evidence from isotopomer analysis of citric acid cycle intermediates. , 1994, The Journal of biological chemistry.

[51]  J. Wahren,et al.  14C-labeled propionate metabolism in vivo and estimates of hepatic gluconeogenesis relative to Krebs cycle flux. , 1993, The American journal of physiology.

[52]  A. Consoli,et al.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. , 1990, The Journal of clinical investigation.

[53]  D. L. Norwood,et al.  Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism , 1990, Journal of Inherited Metabolic Disease.

[54]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[55]  A. Groen,et al.  Control of gluconeogenesis in rat liver cells. Flux control coefficients of the enzymes in the gluconeogenic pathway in the absence and presence of glucagon. , 1986, The Biochemical journal.

[56]  D. Granner,et al.  Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin , 1983, Nature.

[57]  H. J. Sips,et al.  Intracellular Compartment ation and Control of Alanine Metabolism in Rat Liver Parenchymal Cells , 1982 .

[58]  R. Rognstad.  Rate-limiting steps in metabolic pathways. , 1979, The Journal of biological chemistry.

[59]  P. Walter,et al.  Regulation of pyruvate carboxylation by acetyl‐CoA in rat liver mitochondria , 1976, FEBS letters.

[60]  H. Lardy,et al.  Rat liver pyruvate carboxylase. IV. Factors affeing the regulation in vivo. , 1971, The Journal of biological chemistry.

[61]  J. Brosnan,et al.  Effects of ischaemia on metabolite concentrations in rat liver. , 1970, The Biochemical journal.

[62]  O. Wieland,et al.  Intracellular localization of pyruvate carboxylase and phosphoenolpyruvate carboxykinase in rat liver. , 1969, European journal of biochemistry.

[63]  R. Kreisberg,et al.  Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Utter,et al.  PYRUVATE CARBOXYLASE. II. PROPERTIES. , 1963, The Journal of biological chemistry.

[65]  S. Previs,et al.  Stable isotope-based flux studies in nonalcoholic fatty liver disease. , 2018, Pharmacology & therapeutics.

[66]  G. Stephanopoulos,et al.  Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. , 2007, Metabolic engineering.

[67]  R. Hanson,et al.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.

[68]  G. Reaven.  Banting lecture 1988 , 1997 .

[69]  A. Intermediates,et al.  Reversibility of the Mitochondrial Isocitrate Dehydrogenase Reaction in the Perfused Rat Liver , 1994 .

[70]  J. McGarry,et al.  Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.

[71]  H. Krebs,et al.  Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. , 1969, Advances in enzyme regulation.